Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$137,273,575
+$32,982,695 QoQ
Shares Held
114,449
+0.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
1.01%
of 13F equity value
Holder Rank
#330
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ZACKS INVESTMENT MANAGEMENT holds $890,953,075 across 8 Drug Manufacturers - General names. LLY ranks #4 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
875,123 | $222,254,988 | |
| 2 | ABBV |
AbbVie Inc.
|
815,433 | $205,195,560 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,087,644 | $139,762,254 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
114,449 | $137,273,575 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
530,870 | $67,070,115 | |
| 6 | PFE |
Pfizer Inc
|
2,658,388 | $64,013,983 | |
| 7 | AMGN |
Amgen Inc
|
96,618 | $34,987,310 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
353,962 | $20,395,290 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $137,273,575 | 114,449 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $104,290,880 | 113,388 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $123,610,779 | 115,021 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $86,751,574 | 113,698 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $85,322,676 | 109,454 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $89,763,202 | 108,684 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $80,914,092 | 104,811 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $100,957,292 | 113,955 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $93,927,742 | 103,744 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $74,807,077 | 96,158 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $50,944,876 | 87,396 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $47,736,891 | 88,874 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $40,938,671 | 87,293 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $18,133,262 | 52,802 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $34,414,568 | 94,070 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $29,269,642 | 90,520 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $28,712,511 | 88,556 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $19,079,687 | 66,626 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $16,365,758 | 59,249 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $9,309,466 | 40,292 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $410,611 | 1,789 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $326,935 | 1,750 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $291,586 | 1,727 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,360,817 | 29,461 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $11,780,571 | 71,754 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $12,779,718 | 92,126 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||